Dendrimer–doxorubicin conjugate as enzyme-sensitive and polymeric nanoscale drug delivery vehicle for ovarian cancer therapy

Dendrimer–doxorubicin conjugate prepared via click chemistry was employed as enzyme-sensitive nanoscale drug delivery system for ovarian cancer therapy, showing high accumulation in tumor tissue, significantly increased antitumor activity and good biosafety.